Activated protein C prevents glutamate- and thrombin-induced activation of nuclear factor-κB in cultured hippocampal neurons

[1]  Lee D. Hallagan,et al.  Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells. , 2009, The Journal of clinical investigation.

[2]  S. Ishiwata,et al.  Endothelial protein C receptor is expressed in rat cortical and hippocampal neurons and is necessary for protective effect of activated protein C at glutamate excitotoxicity , 2009, Journal of neurochemistry.

[3]  José A Fernández,et al.  Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant. , 2009, Blood.

[4]  J. Bae,et al.  Thrombin inhibits nuclear factor κB and RhoA pathways in cytokine-stimulated vascular endothelial cells when EPCR is occupied by protein C , 2009, Thrombosis and Haemostasis.

[5]  M. Schwaninger,et al.  NF-κB signaling in cerebral ischemia , 2009, Neuroscience.

[6]  P. Spano,et al.  Post‐ischemic brain damage: NF‐κB dimer heterogeneity as a molecular determinant of neuron vulnerability , 2009, The FEBS journal.

[7]  G. Reiser,et al.  Prothrombin/thrombin and the thrombin receptors PAR-1 and PAR-4 in the brain: Localization, expression and participation in neurodegenerative diseases , 2008, Thrombosis and Haemostasis.

[8]  L. March,et al.  New therapeutic applications for the anticoagulant, activated protein C , 2008 .

[9]  S. Ishiwata,et al.  Activated protein C via PAR1 receptor regulates survival of neurons under conditions of glutamate excitotoxicity , 2008, Biochemistry (Moscow).

[10]  A. Baldwin,et al.  Essential Role for Epidermal Growth Factor Receptor in Glutamate Receptor Signaling to NF-κB , 2008, Molecular and Cellular Biology.

[11]  S. Ghosh,et al.  Shared Principles in NF-κB Signaling , 2008, Cell.

[12]  G. Reiser,et al.  Protease-activated receptors in the brain: Receptor expression, activation, and functions in neurodegeneration and neuroprotection , 2007, Brain Research Reviews.

[13]  J. Griffin,et al.  Activated Protein C Mutant with Minimal Anticoagulant Activity, Normal Cytoprotective Activity, and Preservation of Thrombin Activable Fibrinolysis Inhibitor-dependent Cytoprotective Functions* , 2007, Journal of Biological Chemistry.

[14]  C. Kaltschmidt,et al.  Transcription Factor NF-κB Is Transported to the Nucleus via Cytoplasmic Dynein/Dynactin Motor Complex in Hippocampal Neurons , 2007, PloS one.

[15]  L. March,et al.  Endothelial protein C receptor is overexpressed in rheumatoid arthritic (RA) synovium and mediates the anti-inflammatory effects of activated protein C in RA monocytes , 2007, Annals of the rheumatic diseases.

[16]  C. Jackson,et al.  Protein C Is an Autocrine Growth Factor for Human Skin Keratinocytes* , 2007, Journal of Biological Chemistry.

[17]  J. Griffin,et al.  The cytoprotective protein C pathway. , 2007, Blood.

[18]  J. Fischer,et al.  Human Vascular Smooth Muscle Cells Express Functionally Active Endothelial Cell Protein C Receptor , 2007, Circulation research.

[19]  V. Regnault,et al.  Recombinant activated protein C in sepsis: endothelium protection or endothelium therapy? , 2007, Critical care.

[20]  M. Schwaninger,et al.  NF-κB signalling in cerebral ischaemia , 2006 .

[21]  José A Fernández,et al.  Activated protein C inhibits tissue plasminogen activator–induced brain hemorrhage , 2006, Nature Medicine.

[22]  Jung‐Chung Lin,et al.  Inhibition of nuclear factor kappaB is associated with neuroprotective effects of glycyrrhizic acid on glutamate-induced excitotoxicity in primary neurons. , 2006, European journal of pharmacology.

[23]  S. Ishiwata,et al.  Modulation of hippocampal neuron survival by thrombin and factor Xa , 2006, Biochemistry (Moscow).

[24]  J. Griffin,et al.  Protein C anticoagulant activity in relation to anti-inflammatory and anti-apoptotic activities. , 2006, Frontiers in bioscience : a journal and virtual library.

[25]  P. Spano,et al.  Distinct roles of diverse nuclear factor-kappaB complexes in neuropathological mechanisms. , 2006, European journal of pharmacology.

[26]  V. Pinelis,et al.  Factor Xa protects cultured hippocampal neurons from glutamate toxicity , 2006, Journal of thrombosis and haemostasis : JTH.

[27]  K. Abe,et al.  Neuroprotective Effects of Activated Protein C Through Induction of Insulin-Like Growth Factor-1 (IGF-1), IGF-1 Receptor, and Its Downstream Signal Phosphorylated Serine-Threonine Kinase After Spinal Cord Ischemia in Rabbits , 2006, Stroke.

[28]  C. Esmon,et al.  Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow. , 2006, Blood.

[29]  C. Esmon,et al.  Inflammation and the activated protein C anticoagulant pathway. , 2006, Seminars in thrombosis and hemostasis.

[30]  K. Fukudome,et al.  Endothelial protein C receptor and protease-activated receptor-1 mediate induction of a wound-healing phenotype in human keratinocytes by activated protein C. , 2005, The Journal of investigative dermatology.

[31]  K. Ishige,et al.  Distinct nuclear factor-κB/Rel proteins have opposing modulatory effects in glutamate-induced cell death in HT22 cells , 2005, Neurochemistry International.

[32]  C. Kaltschmidt,et al.  Signaling via NF-?B in the nervous system , 2005 .

[33]  V. Pinelis,et al.  Proteinase-Activated Type 1 Receptors are Involved in the Mechanism of Protection of Rat Hippocampal Neurons from Glutamate Toxicity , 2005, Bulletin of Experimental Biology and Medicine.

[34]  Mir Ahamed Hossain.  Molecular mediators of hypoxic–ischemic injury and implications for epilepsy in the developing brain , 2005, Epilepsy & Behavior.

[35]  W. Ruf,et al.  Protease-activated Receptor-1 Signaling by Activated Protein C in Cytokine-perturbed Endothelial Cells Is Distinct from Thrombin Signaling* , 2005, Journal of Biological Chemistry.

[36]  J. Garcia,et al.  Activated Protein C Mediates Novel Lung Endothelial Barrier Enhancement , 2005, Journal of Biological Chemistry.

[37]  C. Feistritzer,et al.  Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. , 2005, Blood.

[38]  Valerie A. Hale,et al.  NF-κB signalling regulates the growth of neural processes in the developing PNS and CNS , 2005, Development.

[39]  V. Pinelis,et al.  Role of Thrombin in Activation of Neurons in Rat Hippocampus , 2004, Bulletin of Experimental Biology and Medicine.

[40]  K. Okajima.  Prevention of endothelial cell injury by activated protein C: the molecular mechanism(s) and therapeutic implications. , 2004, Current vascular pharmacology.

[41]  José A Fernández,et al.  Activated Protein C Prevents Neuronal Apoptosis via Protease Activated Receptors 1 and 3 , 2004, Neuron.

[42]  M. Schwaninger,et al.  Glutamate activates NF‐κB through calpain in neurons , 2003 .

[43]  W. Ruf,et al.  Activated protein C signals through the thrombin receptor PAR1 in endothelial cells , 2003, Journal of endotoxin research.

[44]  O. Benzakour,et al.  Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1. , 2003, Blood.

[45]  José A Fernández,et al.  Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective , 2003, Nature Medicine.

[46]  Li Liu,et al.  Apoptosis in cerebellar granule neurons is associated with reduced interaction between CREB‐binding protein and NF‐κB , 2003, Journal of neurochemistry.

[47]  David S. Park,et al.  Constitutive Nuclear Factor-κB Activity Is Required for Central Neuron Survival , 2002, The Journal of Neuroscience.

[48]  S. Horiuchi,et al.  Activated Protein C Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor-α Production by Inhibiting Activation of both Nuclear Factor-κB and Activator Protein-1 in Human Monocytes , 2002, Thrombosis and Haemostasis.

[49]  B. Grinnell,et al.  Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-&kgr;B , 2002, Critical care medicine.

[50]  M. Krug,et al.  Four different types of protease‐activated receptors are widely expressed in the brain and are up‐regulated in hippocampus by severe ischemia , 2001, The European journal of neuroscience.

[51]  L. Gelbert,et al.  Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis* , 2001, The Journal of Biological Chemistry.

[52]  C. Culmsee,et al.  Apoptotic and antiapoptotic mechanisms in stroke , 2000, Cell and Tissue Research.

[53]  K. Reymann,et al.  The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[54]  C. Gélinas,et al.  Regulation of programmed cell death by NF-kappaB and its role in tumorigenesis and therapy. , 2008, Advances in experimental medicine and biology.

[55]  C. Jackson,et al.  Activated protein C--an anticoagulant that does more than stop clots. , 2008, The international journal of biochemistry & cell biology.